149 related articles for article (PubMed ID: 9453006)
1. Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice.
Kitching AR; Tipping PG; Mutch DA; Huang XR; Holdsworth SR
Kidney Int; 1998 Jan; 53(1):112-8. PubMed ID: 9453006
[TBL] [Abstract][Full Text] [Related]
2. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.
Kitching AR; Tipping PG; Timoshanko JR; Holdsworth SR
Kidney Int; 2000 Feb; 57(2):518-25. PubMed ID: 10652028
[TBL] [Abstract][Full Text] [Related]
3. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis.
Tipping PG; Kitching AR; Huang XR; Mutch DA; Holdsworth SR
Eur J Immunol; 1997 Feb; 27(2):530-7. PubMed ID: 9045927
[TBL] [Abstract][Full Text] [Related]
4. Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice.
Huang XR; Tipping PG; Shuo L; Holdsworth SR
Kidney Int; 1997 Jan; 51(1):94-103. PubMed ID: 8995722
[TBL] [Abstract][Full Text] [Related]
5. IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment.
Kitching AR; Turner AL; Wilson GR; Semple T; Odobasic D; Timoshanko JR; O'Sullivan KM; Tipping PG; Takeda K; Akira S; Holdsworth SR
J Am Soc Nephrol; 2005 Jul; 16(7):2023-33. PubMed ID: 15888563
[TBL] [Abstract][Full Text] [Related]
6. IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis.
Kitching AR; Tipping PG; Holdsworth SR
Eur J Immunol; 1999 Jan; 29(1):1-10. PubMed ID: 9933080
[TBL] [Abstract][Full Text] [Related]
7. Crescentic glomerulonephritis--a manifestation of a nephritogenic Th1 response?
Kitching AR; Holdsworth SR; Tipping PG
Histol Histopathol; 2000 Jul; 15(3):993-1003. PubMed ID: 10963141
[TBL] [Abstract][Full Text] [Related]
8. IL-18 has IL-12-independent effects in delayed-type hypersensitivity: studies in cell-mediated crescentic glomerulonephritis.
Kitching AR; Tipping PG; Kurimoto M; Holdsworth SR
J Immunol; 2000 Oct; 165(8):4649-57. PubMed ID: 11035108
[TBL] [Abstract][Full Text] [Related]
9. Endogenous IL-13 limits humoral responses and injury in experimental glomerulonephritis but does not regulate Th1 cell-mediated crescentic glomerulonephritis.
Kitching AR; Turner AL; Wilson GR; Edgtton KL; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2004 Sep; 15(9):2373-82. PubMed ID: 15339986
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice.
Kitching AR; Tipping PG; Huang XR; Mutch DA; Holdsworth SR
Kidney Int; 1997 Jul; 52(1):52-9. PubMed ID: 9211346
[TBL] [Abstract][Full Text] [Related]
11. An IL-12-independent role for CD40-CD154 in mediating effector responses: studies in cell-mediated glomerulonephritis and dermal delayed-type hypersensitivity.
Ruth AJ; Kitching AR; Li M; Semple TJ; Timoshanko JR; Tipping PG; Holdsworth SR
J Immunol; 2004 Jul; 173(1):136-44. PubMed ID: 15210767
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis.
Kitching AR; Holdsworth SR; Tipping PG
J Am Soc Nephrol; 1999 Apr; 10(4):752-9. PubMed ID: 10203359
[TBL] [Abstract][Full Text] [Related]
13. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559
[TBL] [Abstract][Full Text] [Related]
14. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
J Am Soc Nephrol; 2007 Mar; 18(3):760-70. PubMed ID: 17267745
[TBL] [Abstract][Full Text] [Related]
15. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Timoshanko JR; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2005 Jul; 16(7):2012-22. PubMed ID: 15944341
[TBL] [Abstract][Full Text] [Related]
16. A pathogenetic role for mast cells in experimental crescentic glomerulonephritis.
Timoshanko JR; Kitching AR; Semple TJ; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2006 Jan; 17(1):150-9. PubMed ID: 16319187
[TBL] [Abstract][Full Text] [Related]
17. CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms.
Odobasic D; Kitching AR; Tipping PG; Holdsworth SR
Kidney Int; 2005 Aug; 68(2):584-94. PubMed ID: 16014035
[TBL] [Abstract][Full Text] [Related]
18. Antibody independent crescentic glomerulonephritis in mu chain deficient mice.
Li S; Holdsworth SR; Tipping PG
Kidney Int; 1997 Mar; 51(3):672-8. PubMed ID: 9067898
[TBL] [Abstract][Full Text] [Related]
19. Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation.
Huang XR; Holdsworth SR; Tipping PG
Kidney Int; 1994 Jul; 46(1):69-78. PubMed ID: 7523756
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma production by intrinsic renal cells and bone marrow-derived cells is required for full expression of crescentic glomerulonephritis in mice.
Timoshanko JR; Holdsworth SR; Kitching AR; Tipping PG
J Immunol; 2002 Apr; 168(8):4135-41. PubMed ID: 11937574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
